The expression of the secreted semaphorin SEMA3A was reported to be lower in acute lymphoid and myeloid leukemia (ALL/AML) and chronic myelogenous leukemia (CML) cells, compared to hematopoietic cells found in the normal BM (18). This evidence concerns the gene SEMA3A and acute lymphoblastic leukemia.